Matthew Riordan

As President of Putnam, Matt Riordan leads a team that combines strategic acuity with a mission to advance patient impact. Since stepping into his leadership role at Putnam, he has sought to advance a culture that values rigorous thinking, inclusive teaming, and purposeful execution. He has focused investments in developing people alongside next generation AI platforms and scaling new offerings so clients benefit from sharp frameworks, modern analytics, and field-tested playbooks. Over his 20+ year career at Putnam he has partnered with leading biopharma organizations across therapeutic areas and stages, from pipeline shaping to global launch, bringing structured thinking, objective analysis, and an operator’s bias for results. Matt has helped evolve Putnam’s capabilities and culture, defined by apprenticeship, high standards, and collaborative problem solving. His hallmark is turning complex market signals into clear decisions: what to build, where to invest, and how to win. He believes the best strategies are both analytically sound and eminently executable, and he pushes teams to close the gap between insight and outcome. A lifelong learner and teacher, Matt has lectured at Harvard’s GSAS and holds a BA from Boston College and an MBA from Yale.